Clinical Trials on Carcinogenesis

Total 172 results

Johns Hopkins Bloomberg School of Public Health
Johns Hopkins University; University of Pittsburgh; University of Minnesota; National... and other collaborators

Completed

Broccoli Sprout Intervention in Qidong, P.R. China

Environmental Carcinogenesis

China
Texas Enterosorbents Incorporated
Texas A&M University; University of Georgia; The University of Texas at San Antonio

Completed

Phase 2 Reduction of Dietary Mycotoxin Exposure by ACCS100" (RDMEACCS100)

Dietary Carcinogenesis

United States
Johns Hopkins Bloomberg School of Public Health
National Cancer Institute (NCI); Qidong Liver Cancer Institute

Completed

Broccoli Sprout Dose Response: Bioavailability and Effects of Air Pollutants

Environmental Carcinogenesis

China
Assistance Publique - Hôpitaux de Paris

Unknown

Determination of Carcinogens Nicotine in Electronic Cigarettes Users (CANICE)

Smoking | Carcinogenesis of the Nicotine

France
RenJi Hospital

Not yet recruiting

A Multiomics Study Based on the Dynamic Evolution of Endometrial Carcinogenesis

the Dynamic Evolution of Endometrial Carcinogenesis | Multiomics Analysis
Rush University Medical Center

Active, not recruiting

Abnormal Food Timing and Circadian Dyssynchrony in Alcohol Induced Colon Carcinogenesis (AFT)

Colorectal Cancer

United States
Institut National de Recherche pour l'Agriculture...
Centre de Recherche en Nutrition Humaine d'Auvergne

Completed

Preventive Strategies in Colorectal Carcinogenesis Production and Meat Processing

Colorectal Cancer

France
Assiut University

Unknown

New Genes in the Carcinogenesis of Colorectal Cancer

Colo-rectal Cancer
National Cheng-Kung University Hospital

Recruiting

Study on the Probiotics Regulating miRNA in H. Pylori-induced Wnt/β-catenin Gastric Carcinogenesis.

Carcinogenesis | H. Pylori Infection

Taiwan
Heba Momen kamel

Unknown

Studies of Small DNA Virus Encoded Oncogenes in Viral Carcinogenesis Using Laboratory Model Systems

DNA Virus Infections
Colorado State University

Completed

Diet Composition, Weight Control, and Breast Carcinogenesis (CHOICE)

Breast Cancer

United States
Foundation IRCCS San Matteo Hospital

Active, not recruiting

HPV Immunological Markers of Cervical Persistent Infection and Oncogenesis (HPVImmuno)

HPV-Related Cervical Carcinoma

Italy
Kochi University

Completed

Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids

Liver Cancer

Japan
Vanderbilt-Ingram Cancer Center
National Cancer Institute (NCI); Cancer Prevention Pharmaceuticals, Inc.

Active, not recruiting

Chemoprevention of Gastric Carcinogenesis

Gastric Cancer | Gastric Intestinal Metaplasia

Honduras, Puerto Rico
Seoul National University Bundang Hospital

Active, not recruiting

Comparison of Expression of Carcinogenesis-related Molecular Markers in the Patients With Colon Cancer and Polyp

Colorectal Cancer | Colorectal Adenoma

Korea, Republic of
H. Lee Moffitt Cancer Center and Research Institute
United States Department of Defense

Active, not recruiting

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Pancreatic Cancer

United States
Seoul National University Bundang Hospital
National Research Foundation of Korea

Unknown

CT Carcinogenic Risk in Patients With Appendicitis

Appendicitis | Carcinogenesis | Radiation Exposure | Computed Tomography

Korea, Republic of
Weill Medical College of Cornell University

Recruiting

Changes Associated With H. Pylori and Gastric Carcinogenesis (IIT H pylori)

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)

United States
National Taiwan University Hospital

Unknown

Study on the Carcinogenesis of Gα12 in Oral Cancer, and the Treatment of Oral Cancer Using Ga12 Inhibitor.

Carcinogenesis | Oral Cancer

Taiwan
Institut National de la Recherche Agronomique
Centre de Recherche en Nutrition Humaine d'Auvergne

Completed

Processed Meat and Colon Carcinogenesis (Hemcancer)

Colorectal Cancer

France
National Taiwan University Hospital

Unknown

Study on the Carcinogenesis of SOX-9 in Oral Cancer, and Chemopreventive Possibility for the Treatment of Oral Cancer.

Carcinogenesis | Oral Cancer

Taiwan
Medical College of Wisconsin

Recruiting

Inhibition of Oral Tumorigenesis by Antitumor B

Squamous Cell Cancer of the Oral Cavity

United States
Lei Li

Unknown

HPV Integration and Tumorigenesis of Uterine Cervical Adenocarcinoma

Cervical Adenocarcinoma | Human Papillomavirus | Metabolome | Prognosis | Whole Exome Sequencing | Tumorigenesis | Transcriptome | Genome-wide Association Study

China
National Taiwan University Hospital

Unknown

Expression of VEGF-C and VEGF-CR in Oral Cancers and Premalignant Lesions

Oral Cancer

Taiwan
National Taiwan University Hospital

Completed

The Role of Glycosyltransferases in the Oncogenesis of Neuroblastoma

Neuroblastoma
Sakakibara Heart Institute

Completed

The Sakakibara Health Integrative Profile of Atherosclerotic-Carcinogenesis Hypothesis (SHIP-AC) (SHIP-AC)

Atheroscleroses, Coronary | Atherosclerosis of Artery | Cancers
Yale University

Completed

Switching to Potential Reduced Exposure Products in Adult Smokers (ZYN)

Tobacco Use Disorder | Carcinogenesis | Harm Reduction | Smoking Behaviors | Oral Nicotine Pouch Use | Toxic Effect of Tobacco and Nicotine

United States
National Taiwan University Hospital

Completed

The Role of Aromatic Hydrocarbon Receptor in the Tumorigenesis of Neuroblastoma and Its Relationship With MYCN Expression

Neuroblastoma
Novartis

Completed

STI571 in Treating Patients With Chronic Myelogenous Leukemia in Blast Crisis

Leukemia

United States
Novartis Pharmaceuticals

Approved for marketing

Nilotinib in Adult Patients With Imatinib-resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase (ENACT)

Chronic Myeloid Leukemia

Mexico
Joseph Jurcic
Bristol-Myers Squibb

Recruiting

Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Phase (BP)

Myeloproliferative Neoplasm

United States
University of New Mexico

Withdrawn

Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis

Uterine Neoplasms | Endometrial Neoplasms

United States
Novartis Pharmaceuticals

Completed

A Study of Nilotinib in Adult Patients With Imatinib Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase (ENACT)

Chronic Myeloid Leukemia

Colombia, Venezuela
Novartis Pharmaceuticals

Completed

Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase (MACS0439)

Chronic Myeloid Leukemia

Brazil
Saint Vincent's Hospital, Korea

Completed

Relationship of EBV-positive Gastric Cancer and Multiple Genes Associated With Gastric Carcinogenesis

Gastric Cancer | EBV Infection | MSI

Korea, Republic of
University of Rochester

Completed

Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia

Leukemia

United States
King Faisal Specialist Hospital & Research Center

Completed

An Open-Label, Multicenter, Expanded Access Study of Oral AMN 107 in Adult Patients With Imatinib (Glivec®/Gleevec®_ - Resistant or Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase

Leukemia, Myeloid, Chronic
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Chemotherapy in Treating Children With Relapsed Acute Leukemia, Acute Myeloid Leukemia, or Blastic Phase Chronic Myelogenous Leukemia

Leukemia

United States, Australia, Canada
University of Bologna

Completed

Protein-Tyrosine Kinase Inhibitor (STI571) for Treatment of Patients With Ph+ Chronic Myeloid Leukemia in Accelerated and Blastic Phase (CML003)

Chronic Myeloid Leukemia

Italy
Novartis Pharmaceuticals

Terminated

Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase

Leukemia, Myeloid, Chronic

United States, Germany
Bristol-Myers Squibb

Completed

Dasatinib (BMS-354825) in Subjects With Myeloid Blast Phase Chronic Myeloid Leukemia Resistant to or Intolerant of Imatinib Mesylate

Chronic Myeloid Leukemia | Blast Crisis

Netherlands, United States, Italy, Austria, Canada, France, Germany, Singapore, Taiwan, United Kingdom, Australia, Korea, Republic of, Philippines, Sweden, Finland, Israel, Belgium, Denmark, Norway, Switzerland
Samus Therapeutics, Inc.

Withdrawn

A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN (AP-MPN)

Accelerated Phase MPN | Blast Phase MPN
M.D. Anderson Cancer Center
Bristol-Myers Squibb

Terminated

An Open-Label, Phase I/II Study of Two Different Schedules of Dasatinib (Sprycel) and Decitabine (Dacogen) Used in Combination for Patients With Accelerated or Blastic Phase Chronic Myelogenous Leukemia (Protocol CA180357)

Leukemia

United States
Astex Pharmaceuticals, Inc.
Eisai Inc.

Completed

Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Blast Phase Who Are Refractory to Imatinib Mesylate (Gleevec)

Chronic Myelogenous Leukemia

United States, Canada
University of Jena

Recruiting

European CML Blast Crisis Register (BlastCrisis)

Chronic Myeloid Leukemia in Myeloid Blast Crisis

Germany, Czechia, Russian Federation, Ukraine
Novartis Pharmaceuticals

Completed

Study of Oral AMN107 (Nilotinib) in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase Previously Enrolled to CAMN107A2109 Trial

Chronic Myelogenous Leukemia

Poland
National Taiwan University Hospital

Unknown

Expression of Altered Glycosyltransferases, Mucins, and RTKs in Human Ovarian and Endometrial Cancers

Ovarian Cancer | Carcinogenesis | Endometrial Cancer
Novartis Pharmaceuticals

No longer available

Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant

Chronic Myelogenous Leukemia

Canada
University of Cincinnati
Novartis

Withdrawn

A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia

Acute Myeloid Leukemia | Chronic Myeloid Leukemia, Blast Crisis

United States
Columbia University

Terminated

Validation of a Mouse Model of Pancreatic Carcinogenesis

Pancreatic Cancer

United States

Clinical Trials on Carcinogenesis

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations